Ductal carcinoma of the prostate might be the primary diagnosis or an incidental finding mixed with acinar adenocarcinoma during pathologic examination.
Ibcasertib is under clinical development by Shenzhen Chipscreen Biosciences and currently in Phase II for Non-Hodgkin Lymphoma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback